BETAMETHASONE (AS DIPROPIONATE) 0.05% WITH SALICYLIC ACID 3% (Diprosalic®)

Clinical Indication

Inflammatory skin disorders

Comments

Available as ointment and scalp application.

Date of classification

October 2023

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.